Sign up
Pharma Capital
Market: AIM
52-week High/Low: 127.20p / 68.00p
Sector: Pharma & Biotech
Market Cap: 541.82M

Vectura Group plc, (Vectura) along with its subsidiaries, is principally engaged in the research and development of therapeutic products and drug delivery systems for human use. The Company is focused on the development of inhaled pharmaceuticals. It has eight marketed products and a portfolio of drugs in clinical and pre-clinical development, some of which have been licensed to...

Vectura Group PLC

Interactive graph

col 3
col 4
col 5
col 6
View full VEC profile View Profile
View All

Market Reports Including VEC


© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.